Latest news with #SAWC
TimesLIVE
27-05-2025
- General
- TimesLIVE
Southern African Wildlife College gets accreditation for national diploma
The Southern African Wildlife College (SAWC) says its flagship diploma in applied natural resource management has now received all formal accreditations with an official registration number from the relevant national regulatory bodies. 'We will enrol our first group of first-year students in January 2026 and encourage interested parties to keep an eye on our website and communications platforms for further updates and application details,' the college said on Tuesday. It said the milestone followed a rigorous multiyear process to ensure the programme met the highest academic and professional standards. 'With accreditation secured from the Council on Higher Education at the end of 2024, and with the recent and subsequent registration of the qualification by the South African Qualifications Authority, the college is pleased to confirm that the diploma is now fully recognised as a nationally registered qualification at NQF Level 6.' The college said the three-year diploma had been developed to respond to the real-world needs of protected area managers and conservation practitioners working across Southern Africa. 'It blends academic learning (two years online with annual practical blocks at the SAWC campus) with intensive field-based application (third year fully applied), ensuring graduates are equipped with the knowledge and practical skills required to manage natural resources effectively and holistically.'
Sunday Post
25-05-2025
- Politics
- Sunday Post
Anglers fear anti-cruelty laws will be extended to include fishing
Get a weekly round-up of stories from The Sunday Post: Thank you for signing up to our Sunday Post newsletter. Something went wrong - please try again later. Sign Up Anglers in Scotland fear their sport may be criminalised after Scottish Government animal welfare experts recommended anti-cruelty laws be extended to include fishing. The Scottish Animal Welfare Commission (SAWC), an independent body that advises ministers, has published a report arguing fish are sentient beings and deserve the same legal protection as other creatures such as sheep, cattle, cats and dogs. Among its recommendations is amending regulations to cover 'actions that occur in the normal course of fishing'. Such a move could outlaw many aspects of angling such as hooking a fish and removing it from the water. In the report, the SAWC singles out the practice of 'catch-and-release' as particularly harmful to fish – even though it is a key part of coarse fishing and is actively encouraged on many Scottish rivers as the best way to preserve salmon stocks. Fishermen have reacted with fury at the prospect of such measures. Kirk Norbury, of Country Sport Scotland, said: 'Anglers could be exposed to legal action for carrying out normal and accepted fishing practices such as casting, landing, briefly handling fish, using a net, and releasing them safely. These actions are done with care and in line with high welfare standards, especially in catch-and-release angling.' He added: 'Further restrictions on fishing would risk damaging rural communities and local businesses that rely on visiting anglers. This potential change in the law would cause significant damage to the very efforts of the people who do the most to protect our rivers and fish stocks.' In February, the SAWC was at the centre of an international outcry after it suggested banning cat ownership in some parts of the country in a bid to protect small mammals and birds. First Minister John Swinney was later forced to deny the SNP government was planning to ban pet cats. In its latest report the SAWC states: 'Given that fish are sentient, their welfare needs should receive the same consideration in the formulation and implementation of policy as those of terrestrial vertebrate species.' The main law protecting animals north of the border is the Animal Health and Welfare (Scotland) Act 2006. However, activities that occur in 'the normal course of fishing' are exempt. According to the SAWC, this means fish can be subjected to treatment which would be considered cruel if it involved other animals such as pets or livestock. The report states: 'Some of those acts would be illegal if committed against other protected animals in comparable circumstances.' In particular it highlights the practice of 'catch-and-release' which, it states, 'leads to the injuring of sentient animals, a significant proportion of whom may die following the experience'. To address this, the report calls for changes in guidance for fishermen, saying: 'Catch-and-release practices in game, coarse and sea angling should be given further consideration by the sports' governing bodies and associations, in consultation with fish welfare experts.' Significantly, it also recommends ministers change the law, stating that 'the exclusion under Section 47(b) of the Animal Health and Welfare (Scotland) Act 2006 relating to acts carried out in the 'normal course of fishing' should be reviewed in the light of the current scientific evidence of fish sentience'. Last night the Scottish Government said it had no immediate plans to change the law regarding angling, but would consider the SAWC's report 'in due course', adding: 'Fish farming, sea fisheries and angling are all cornerstones of Scottish national and local economies.' Tory rural affairs and fishing spokesperson Tim Eagle said: 'A heavy-handed approach from this SNP-backed quango is not the way to go about things. 'Instead of announcing proposals like this out the blue, these bureaucrats should be engaging with anglers and recognising its importance to Scotland's economy.'
The Citizen
17-05-2025
- Health
- The Citizen
SABHSSA hosts hunting clinic at SA Wildlife College
LIMPOPO – Driven by a clear and transformative vision, the South African Black Hunters Sport Shooters Association (SABHSSA) took a historic step forward by hosting its first hunting clinic from Thursday, May 1, to Sunday, May 4, at the Southern African Wildlife College (SAWC) in Hoedspruit. The clinic embodied SABHSSA's commitment to developing a new generation of ethical, skilled, and inclusive hunting professionals. With the theme 'Reimagining South Africa's professional hunting industry: Unlocking opportunities through transformation and inclusion,' the clinic paved the way for a hunting sector that reflects South Africa's diversity and advocates responsible resource use. The event was jointly facilitated by Dr Thabang Teffo, responsible resource management head at SAWC, and Frans Malebane, CEO of SABHSSA. Together, they guided discussions and activities that emphasised transformation, ethics, and hands-on skills development. 'This inaugural clinic reflects SABHSSA's commitment to nurturing a new generation of competent, ethical, and dedicated hunting professionals,' said Malebane. 'It is essential that both the client and the professional hunter are kept safe at all times while in the bush. Building these skills is not only about professionalism but about safety, ethical conduct, and creating a transformative industry future that is inclusive and responsible,' he added. The clinic brought together aspiring hunters, leaders from community property associations (CPA) such as KwaMalawuza CPA, and key supporters like the Custodians of Professional Hunting and Conservation South Africa (CPHC-SA). The four-day clinic delivered a robust programme that covered critical areas such as basic tracking, hunting ethics, firearm ownership, and practical shooting. A field trip to the Timbavati Private Game Reserve provided participants with firsthand exposure to game harvesting techniques, abattoir protocols, skinning and salting processes, and tannery practices. These real-world lessons were complemented by a visit to the Graeme Naylor Museum, deepening attendees' understanding of South Africa's conservation and hunting heritage. Pieter Nel, a SAWC senior trainer in regenerative land practices, provided expert guidance on firearm handling and responsible hunting, while also explaining ballistic performance and proper shot placement for both African plains game and dangerous game. 'Hunters should understand that the aim is not to hurt the animal but to kill it,' he explained. He also led the afternoon shooting sessions, guiding participants through hands-on exercises with both a 22 rifle and the powerful 4.75 heavy rifle, which delivered an adrenaline-charged experience that challenged even the most seasoned hunters. The clinic wrapped up on an exciting note with a paintball shoot-out, where participants put their teamwork, tactical thinking, and shooting skills to the test in a spirited and engaging finale. One of the attendees, Komape Everson Manoko, reflected on the experience. 'When I recently joined SABHSSA, I did not know what to expect. I simply wanted to be part of an organisation that values and champions transformation. This first clinic exceeded all my expectations, from formal boardroom discussions on conservation and law to fireside storytelling and personal experiences. The session on approaching dangerous game on foot was particularly fascinating and fun. I look forward to more exciting events like this and encourage everyone who cares about nature and conservation to get involved.' The success of the hunting clinic is set to become an annual event. The next hunting clinic will be announced soon. For more information or to become a member, contact: info@ At Caxton, we employ humans to generate daily fresh news, not AI intervention. Happy reading!
Yahoo
28-04-2025
- Business
- Yahoo
MediWound to Present New EscharEx® Data at Leading Wound Care Conferences
Presentations at WHS and SAWC to highlight EscharEx's mechanism of action, preclinical advantages over SANTYL®, and new data in treating VLUs and DFUs Findings reinforce the ongoing Phase III study in VLUs and support the planned DFU trial strategy YAVNE, Israel, April 28, 2025 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that it will present 10 scientific abstracts—including both oral and poster presentations—at two of the world's premier wound care conferences: the Wound Healing Society (WHS) and the Symposium on Advanced Wound Care (SAWC) Spring 2025, taking place April 30–May 3 in Grapevine, Texas. The presentations will feature new preclinical and clinical data on EscharEx®, MediWound's investigational enzymatic therapy for chronic wounds. The findings offer important insights into EscharEx's multitargeted and selective mechanism of action, reinforcing the ongoing VALUE Phase III study in venous leg ulcers (VLUs) and supporting the planned clinical trial in diabetic foot ulcers (DFUs). Key presentation highlights include: Wound Healing Society (WHS) New in vitro data highlighting EscharEx' s multitargeted and selective proteolytic activity on non-viable tissue Results from a novel hard-to-heal wound model demonstrating EscharEx's superior debridement efficacy compared to collagenase SANTYL® Symposium on Advanced Wound Care (SAWC) Overview of EscharEx's mechanism of action, including in vitro studies and clinical findings from EscharEx and NexoBrid® Case studies highlighting EscharEx's use in advanced DFUs (Wagner grade ≥2) and VLUs Post-hoc analyses in DFUs and preliminary strategy for the planned clinical trial Update on the VALUE Phase III study design and enrollment progress 'These new data further validate EscharEx's unique mechanism of action and its potential to redefine the standard of care for chronic wound management,' said Dr. Robert Snyder, Chief Medical Officer at MediWound. 'We remain committed to advancing EscharEx through rigorous clinical development, with the goal of offering a meaningful, non-surgical solution for patients suffering from chronic wounds.' The VALUE Phase III study is currently enrolling patients with VLUs across multiple sites, building on positive results from three completed Phase II studies that demonstrated EscharEx's efficacy, safety, and potential to enhance standard wound care practices. About EscharEx® EscharEx® is a bromelain-based, bioactive enzymatic therapy in advanced clinical development for the debridement of chronic and hard-to-heal wounds. Designed for topical, once-daily application, EscharEx has demonstrated a favorable safety profile and effective wound bed preparation in multiple Phase II trials. The therapy has shown the ability to remove non-viable tissue, promote granulation, and reduce bioburden and biofilm. A global Phase III study in venous leg ulcers (VLUs) is currently underway, with a Phase II/III study in diabetic foot ulcers (DFUs) in preparation. EscharEx has shown clinical advantages over the leading enzymatic debridement product and targets a substantial global market opportunity. About MediWound Ltd. MediWound Ltd. (Nasdaq: MDWD) is a global biotechnology company focused on developing and commercializing enzymatic therapies for non-surgical tissue repair. The company's FDA-approved biologic, NexoBrid®, is indicated for the enzymatic removal of eschar in thermal burns and is marketed in the U.S., European Union, Japan, and other international markets. MediWound is also advancing EscharEx®, a late-stage investigational therapy for the debridement of chronic wounds. EscharEx has demonstrated clinical advantages over the leading enzymatic debridement product and targets a substantial global market opportunity. For more information, visit and follow us on LinkedIn. About the Symposium on Advanced Wound Care (SAWC) The Symposium on Advanced Wound Care (SAWC) Spring, co-hosted with the Wound Healing Society, is one of the largest multidisciplinary wound care conferences in the world. Now in its 38th year, the event convenes physicians, nurses, podiatrists, researchers, and other professionals to share the latest advances in clinical care and research. About the Wound Healing Society (WHS) The Wound Healing Society is a nonprofit organization dedicated to advancing the science and practice of wound healing. WHS promotes collaboration across clinical, academic, and industry stakeholders and publishes the peer-reviewed journal Wound Repair and Regeneration. The Society also co-hosts the SAWC Spring conference and publishes Advances in Wound Care. Cautionary Note Regarding Forward-Looking Statements MediWound cautions you that all statements other than statements of historical fact included in this press release that address activities, events, or developments that we expect, believe, or anticipate will or may occur in the future are forward-looking statements. Although we believe that we have a reasonable basis for the forward-looking statements contained herein, they are based on current expectations about future events affecting us and are subject to risks, assumptions, uncertainties, and factors, all of which are difficult to predict and many of which are beyond our control. Actual results may differ materially from those expressed or implied by the forward-looking statements in this press release. These statements are often, but are not always, made through the use of words or phrases such as 'anticipates,' 'intends,' 'estimates,' 'plans,' 'expects,' 'continues,' 'believe,' 'guidance,' 'outlook,' 'target,' 'future,' 'potential,' 'goals' and similar words or phrases, or future or conditional verbs such as 'will,' 'would,' 'should,' 'could,' 'may,' or similar this press release contains forward-looking statements concerning the anticipated progress, development, study design, expected data timing, objectives anticipated timelines, expectations and commercial potential of our products and product candidates, including EscharEx®. Among the factors that may cause results to be materially different from those stated herein are the inherent uncertainties associated with the uncertain, lengthy and expensive nature of the product development process; the timing and conduct of our studies of our products and product candidates, including the timing, progress and results of current and future clinical studies, and our research and development programs; the approval of regulatory submission by the FDA, the European Medicines Agency or by any other regulatory authority, our ability to obtain marketing approval of our products and product candidates in the U.S. or other markets; the clinical utility, potential advantages and timing or likelihood of regulatory filings and approvals of our products and products; our expectations regarding future growth, including our ability to develop new products; market acceptance of our products and product candidates; our ability to maintain adequate protection of our intellectual property; competition risks; the need for additional financing; the impact of government laws and regulations and the impact of the current global macroeconomic climate on our ability to source supplies for our operations or our ability or capacity to manufacture, sell and support the use of our products and product candidates in the future. These and other significant factors are discussed in greater detail in MediWound's annual report on Form 20-F for the year ended December 31, 2024, filed with the Securities and Exchange Commission ('SEC') on March 19, 2025 and Quarterly Reports on Form 6-K and other filings with the SEC from time-to-time. These forward-looking statements reflect MediWound's current views as of the date hereof and MediWound undertakes, and specifically disclaims, any obligation to update any of these forward-looking statements to reflect a change in their respective views or events or circumstances that occur after the date of this release except as required by law. MediWound Contacts: Hani Luxenburg Daniel Ferry Chief Financial Officer Managing Director MediWound Ltd. LifeSci Advisors, LLC ir@ daniel@ Media Contact: Ellie Hanson FINN Partners for MediWound 929-588-2008 Sign in to access your portfolio
Associated Press
08-04-2025
- Health
- Associated Press
WHS receives record number of abstracts; event to feature First-To-Podium research
Wound care research accepted at HMP Global symposium to be published in industry-leading Wounds journal, showcasing the latest innovations in wound care. 'As the world's leading wound care event, SAWC Spring | WHS continues to push the boundaries and make a difference in wound care together through research, education, innovation, and collaboration.' — John C. Lantis II, MD, FACS, Editor-in-Chief of Wounds MALVERN, PA, UNITED STATES, April 8, 2025 / / -- The Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS) received a record-breaking number of abstract submissions for its 2025 meeting, solidifying its position as the top forum for wound care innovation and education. The educational program at the HMP Global event will feature First-To-Podium presentations of practice-changing research from the leading minds in the field. SAWC Spring | WHS will be held April 30-May 4 in Grapevine, Texas. Abstracts accepted for presentation will also be published in the industry-leading Wounds journal, the most widely read, peer-reviewed journal focusing on wound care and wound research. Wounds is the official publication for SAWC and is indexed in MEDLINE/PubMED. SAWC Spring received 413 abstract submissions, with an additional 73 submitted to WHS. That unprecedented number of abstract submissions surpasses the record SAWC Fall number of 391 submissions and the SAWC Spring 2024 number of 378 submissions. 'The increasing number of submitted abstracts reflects the growing interest and advancements in wound care research,' said John C. Lantis II, MD, FACS, Editor-in-Chief of Wounds. 'As the world's leading wound care event, SAWC Spring | WHS continues to push the boundaries and make a difference in wound care together through research, education, innovation, and collaboration.' The First-To-Podium presentations, Abstract & Founders Award ceremony will take place on Friday, May 2, at 7:15 p.m., followed by the Poster Reception. Lantis noted that these presentations will highlight some of the most impactful and innovative research in wound care. Abstracts span a wide range of categories, including case studies, laboratory and clinical research, evidence-based practice, practice innovations and health economics. Posters will be on display in the Poster Hall on Friday, May 2, and Saturday, May 3, from 7:30 a.m. to 5 p.m., and on multimedia screens throughout the conference space. ePosters will also be available for viewing in the mobile app, ensuring attendees have ample opportunities to engage with the latest research. Educational Program SAWC Spring | WHS 2025 will deliver more than 80 high-impact sessions led by over 200 faculty experts. The Exhibit Hall will feature scores of industry supporters showcasing the latest wound care technology, equipment and services. The partnership between WHS and SAWC Spring amplifies the power of collaboration: 'The relationship between the SAWC Spring and WHS is advancing patient care, fueling research and fostering the exchange of ideas and best practices, said Tiffney Oliver, Vice President, Wound Care Learning Network, HMP Education. In addition to a WHS annual meeting track at SAWC Spring/WHS, the Wound Care Business Navigator will dive into the realities of delivering healthcare beyond the clinical scope, focusing on critical business topics including coding, coverage and payment, regulations and more. Designed for a wide range of healthcare professionals, including physicians, nursing professionals, podiatrists, physician assistants, physical therapists, researchers, scientists, dietitians, and healthcare marketing and sales professionals as well as medical students, residents and fellows, SAWC Spring | WHS offers a spectrum of educational and networking opportunities. For more information or to register, visit the SAWC Spring | WHS website. About HMP Global HMP Global is the omnichannel market leader in healthcare events, education, and insight — with a mission to improve patient care. For 40 years, the company has built trusted brands including Psych Congress, the premier source for mental health education, and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. HMP Global partners with leading experts around the world to deliver more than 450 annual events, medical strategy, and marketing for pharmaceutical and medical device customers through HMP Collective, and pharmaceutical market insight, engaging a global community of healthcare stakeholders that includes nearly 2 million clinicians across 600 medical specialties as well as managed care, behavioral health, senior living, emergency medical, and pharmaceutical commercialization professionals. For more information, follow HMP Global on LinkedIn or visit Sandi Beason, APR Legal Disclaimer:
